Inflammasomes and adaptive immune responses

KA Deets, RE Vance - Nature immunology, 2021 - nature.com
A fundamental concept in immunology is that the innate immune system initiates or instructs
downstream adaptive immune responses. Inflammasomes are central players in innate …

The hygiene hypothesis in autoimmunity: the role of pathogens and commensals

JF Bach - Nature Reviews Immunology, 2018 - nature.com
The incidence of autoimmune diseases has been steadily rising. Concomitantly, the
incidence of most infectious diseases has declined. This observation gave rise to the …

Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis

BA McKenzie, MK Mamik, LB Saito… - Proceedings of the …, 2018 - National Acad Sciences
Multiple sclerosis (MS) is a progressive inflammatory demyelinating disease of the CNS of
unknown cause that remains incurable. Inflammasome-associated caspases mediate the …

MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration

E Lee, I Hwang, S Park, S Hong, B Hwang… - Cell Death & …, 2019 - nature.com
Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by the
loss of dopaminergic neurons in the substantia nigra (SN) and the reduction of dopamine …

NLRP3 inflammasome in neurological diseases, from functions to therapies

L Song, L Pei, S Yao, Y Wu, Y Shang - Frontiers in cellular …, 2017 - frontiersin.org
Neuroinflammation has been identified as a causative factor of multiple neurological
diseases. The nucleotide-binding oligomerization domain-, leucine-rich repeat-and pyrin …

Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia

Y Liu, Y Dai, Q Li, C Chen, H Chen, Y Song, F Hua… - Neuroscience …, 2020 - Elsevier
Highlights•Aβ 1− 42-induced NLRP3 inflammasome activation in BV-2 microglia is mediated
through TLR4.•TLR4/NLRP3 signaling plays a critical role in Aβ 1− 42-induced …

NLRP3 inflammasome in neurodegenerative disease

FL Anderson, KE Biggs, BE Rankin, MC Havrda - Translational Research, 2023 - Elsevier
Neurodegenerative diseases are characterized by a dysregulated neuro-glial
microenvironment, culminating in functional deficits resulting from neuronal cell death …

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

S Malhotra, C Costa, H Eixarch, CW Keller, L Amman… - Brain, 2020 - academic.oup.com
Primary progressive multiple sclerosis is a poorly understood disease entity with no specific
prognostic biomarkers and scarce therapeutic options. We aimed to identify disease activity …

Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis‐related NLRP3 pathway

S Song, R Guo, A Mehmood, L Zhang… - CNS neuroscience & …, 2022 - Wiley Online Library
Aims Multiple sclerosis (MS) still maintains increasing prevalence and poor prognosis, while
glucagon‐like peptide‐1 receptor (GLP‐1R) agonists show excellent neuroprotective …

Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases

X Zhang, A Xu, J Lv, Q Zhang, Y Ran, C Wei… - European journal of …, 2020 - Elsevier
NLRP3 (Nod-like receptor protein 3) belongs to the NOD-like receptor family, which is
activated by pathogen and damage-associated signals to form a multimeric protein complex …